Updated Jul 16, 2026 · Last SEC filing 2026-07-07
Pelthos Therapeutics Inc. (PTHS) has filed 7 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-07. 3 Form 8-K material event filings were reported by PTHS in the last 90 days. 1 Form 144 notices of proposed sale were filed for PTHS stock. InsiderAlpha tracks every PTHS SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001919246 |
|---|
| Form 4 filings (90d) | 7 |
|---|---|
| Form 8-K filings (90d) | 3 |
| Form 144 notices (90d) | 1 |
| Latest Form 4 filing | 2026-07-07 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Pauls Matthew | Director | S — Open-market sale | 94 | $27.36 | $3K | SEC | |
| Greenleaf Peter | Director | S — Open-market sale | 85 | $27.27 | $2K | SEC | |
| Friedberg Ezra M | Director | S — Open-market sale | 24 | $27.33 | $656 | SEC | |
| Pauls Matthew | Director | S — Open-market sale | 692 | $26.00 | $18K | SEC | |
| Friedberg Ezra M | Director | S — Open-market sale | 534 | $26.03 | $14K | SEC | |
| Greenleaf Peter | Director | S — Open-market sale | 712 | $26.00 | $19K | SEC | |
| Friedberg Ezra M | Director | S — Open-market sale | 224 | $27.12 | $6K | SEC | |
| Friedberg Ezra M | Director | S — Open-market sale | 59 | $27.94 | $2K | SEC | |
| Davis Todd C | Director | P — Open-market purchase | 503 | $28.73 | $14K | SEC | |
| Davis Todd C | Director | P — Open-market purchase | 35.4K | $27.80 | $986K | SEC | |
| Francis Knuettel II | CFO, Treas & Secty | S — Open-market sale | 1.5K | $26.84 | $40K | SEC | |
| Francis Knuettel II | CFO, Treas & Secty | D — Derivative transaction | 13.9K | $0.00 | — | SEC | |
| Friedberg Ezra M | Director | F — Tax withholding / forfeiture | 144 | $27.01 | $4K | SEC | |
| Friedberg Ezra M | Director | S — Open-market sale [10b5-1] | 265 | $21.36 | $6K | SEC | |
| Pauls Matthew | Director | S — Open-market sale [10b5-1] | 415 | $20.52 | $9K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Pelthos Therapeutics Inc. (PTHS). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Friedberg Ezra M | 5 | $26K |
| Francis Knuettel II | 4 | $40K |
| Greenleaf Peter | 2 | $21K |
| Davis Todd C | 2 | $1000K |
| Pauls Matthew | 2 | $21K |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in PTHS insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live PTHS dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.